Reshape Biotech
PrivateLast Round
Series A
Apr 9, 2024
Est. Valuation
$1.79M
Total Funding Raised
$29.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Reshape Biotech is a biotechnology company that develops an AI and robotics-powered platform to automate laboratory experiments for the food, agriculture, and biotech sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Workflow Automation, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reshape Biotech Comparables
Compare Reshape Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singer Instruments | 80% | |
| Microtechnix | 79% | |
| Automata | 78% |
Reshape Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2024 | ||||
| Seed | Feb 9, 2023 | ||||
| Pre Seed | May 23, 2021 | ||||
| Accelerator | Mar 23, 2021 |
Key People
Founding team and executive leadership
Reshape Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Astanor Ventures | Series A |
| R7 Partners | Series A |
| Y Combinator | Accelerator, Seed, Series A, Pre Seed |
| Sherpa Capital | Series A, Seed |
| Look Up Ventures | Seed |
| FundersClub | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2026
Added The Clockwork Group SAS, a biotechnology startup, as a customer.
- Dec 8, 2025
Added Ventera Bio, a biotechnology startup, as a customer.
Reshape Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reshape Biotech's valuation, stock price, and market status.
Is Reshape Biotech a public or private company?
Reshape Biotech is a private company.
What is the current stock price of Reshape Biotech?
Reshape Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Reshape Biotech worth (valuation)?
Valuation information for Reshape Biotech is not publicly available.
Can I buy Reshape Biotech stock?
Reshape Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Reshape Biotech's last funding round?
Reshape Biotech's most recent funding round was Series A on April 9, 2024.
Who are the main investors in Reshape Biotech?
Key investors in Reshape Biotech include Astanor Ventures, Sherpa Capital, FundersClub.
Will Reshape Biotech IPO soon?
No public IPO plans have been announced for Reshape Biotech.
How can I track Reshape Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reshape Biotech's secondary market activity and sign up for updates.